Skip to main content
OpenTrials
Completed

NCT Number: NCT04327479

Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infects host-cells via ACE2-receptors, which leads to pneumonia (COVID-19) but also can lead to myocarditis (acute myocardial injury) and chronic damage to the cardiovascular system. Therefore, cardiovascular protection may be necessary when treating patients with COVID-19 infection. This may especially be necessary in patients with cardiovascular diseases, risk factors, and co-medication.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiovascular Diseases Cardiovascular Risk Factor SARS

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Essen

Essen, North Rhine-Westphalia, 45147, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with suspected SARS-CoV2/Covid-19 infection

Exclusion criteria

  • Unwillingness to participate

Treatment and study plan

Assessment of cardiovascular diseases and cardiovascular risk factors

Diagnostic Test

At inclusion, patients will be screened for pre-existing cardiovascular diseases and cardiovascular risk factors, as well as medication.

Primary outcomes

  1. All-cause mortality

    Time frame: During 1 year follow-up

    mortality of any cause

Secondary outcomes

  1. 30-day mortality

    Time frame: Within 30 days after inclusion

    mortality of any cause

  2. Major adverse cardiovascular events

    Time frame: During 1 year follow-up

    Myocardial infarction, stroke, or CV death

Sponsors and collaborators

Lead sponsor

University Hospital, Essen

Other

Registry information

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Mar 31, 2020
Registry last updated
Nov 3, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.